Award
University of Washington Medical Center BL1933256U-054
PHARMACEUTICALS FOR HUMAN USE SALES TAX EXEMPT LIMITED DISTRIBUTION MEDICATIONS
Recipient
BIOGEN DIRECT
Award Amount
$23,600.00
Ceiling
$23,600.00
Awarded
June 15, 2022
Identifier
BL1933256U-054
The University of Washington Medical Center, a public hospital in Washington state, issued a purchase order on June 15, 2022, to Biogen Direct for pharmaceuticals intended for human use, specifically sales tax exempt limited distribution medications. The order amount was $23,600.00, and the procurement involved a single line item with a quantity of one at a unit price of approximately $23,600.85. The purchase was for pharmaceuticals categorized under medical supplies, and the contract appears to be a single-transaction order. The award is part of the hospital's procurement activities for medical supplies and pharmaceuticals, with no indication of a multi-year or blanket arrangement.
Description
PHARMACEUTICALS FOR HUMAN USE SALES TAX EXEMPT LIMITED DISTRIBUTION MEDICATIONS